Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1949 1
1954 2
1960 1
1963 1
1965 2
1967 1
1969 1
1970 1
1972 1
1973 1
1974 1
1975 5
1976 2
1978 2
1979 3
1980 2
1981 1
1982 4
1983 4
1984 8
1985 2
1986 2
1987 2
1988 8
1989 3
1990 5
1991 3
1992 3
1993 5
1994 4
1995 9
1996 12
1997 4
1998 6
1999 10
2000 8
2001 7
2002 10
2003 12
2004 10
2005 11
2006 19
2007 18
2008 8
2009 14
2010 18
2011 16
2012 17
2013 24
2014 17
2015 25
2016 27
2017 24
2018 21
2019 28
2020 32
2021 28
2022 25
2023 31
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

531 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ, Kerr K, Wang C, Ciuleanu TE, Saylors GB, Tanaka F, Ito H, Chen KN, Liberman M, Vokes EE, Taube JM, Dorange C, Cai J, Fiore J, Jarkowski A, Balli D, Sausen M, Pandya D, Calvet CY, Girard N; CheckMate 816 Investigators. Forde PM, et al. Among authors: liberman m. N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11. N Engl J Med. 2022. PMID: 35403841 Free PMC article. Clinical Trial.
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Keller SM, Samkari A, Spicer JD; KEYNOTE-671 Investigators. Wakelee H, et al. Among authors: liberman m. N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3. N Engl J Med. 2023. PMID: 37272513 Clinical Trial.
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
Altorki N, Wang X, Kozono D, Watt C, Landrenau R, Wigle D, Port J, Jones DR, Conti M, Ashrafi AS, Liberman M, Yasufuku K, Yang S, Mitchell JD, Pass H, Keenan R, Bauer T, Miller D, Kohman LJ, Stinchcombe TE, Vokes E. Altorki N, et al. Among authors: liberman m. N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083. N Engl J Med. 2023. PMID: 36780674 Free PMC article. Clinical Trial.
Sensory Neuron Diversity in the Inner Ear Is Shaped by Activity.
Shrestha BR, Chia C, Wu L, Kujawa SG, Liberman MC, Goodrich LV. Shrestha BR, et al. Among authors: liberman mc. Cell. 2018 Aug 23;174(5):1229-1246.e17. doi: 10.1016/j.cell.2018.07.007. Epub 2018 Aug 2. Cell. 2018. PMID: 30078709 Free PMC article.
Energized lung resections.
Liberman M. Liberman M. J Thorac Cardiovasc Surg. 2019 Jan;157(1):396. doi: 10.1016/j.jtcvs.2018.03.036. Epub 2018 Mar 17. J Thorac Cardiovasc Surg. 2019. PMID: 29636191 Free article. No abstract available.
Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy: A Prospective Multi-Centre Agreement Clinical Trial (CAN-ICE).
Fortin M, Liberman M, Delage A, Dion G, Martel S, Rolland F, Soumagne T, Trahan S, Assayag D, Albert E, Kelly MM, Johannson KA, Guenther Z, Leduc C, Manganas H, Prenovault J, Provencher S. Fortin M, et al. Among authors: liberman m. Am J Respir Crit Care Med. 2023 Jun 15;207(12):1612-1619. doi: 10.1164/rccm.202209-1812OC. Am J Respir Crit Care Med. 2023. PMID: 36796092
Ultrastructure of noise-induced cochlear synaptopathy.
Moverman DJ, Liberman LD, Kraemer S, Corfas G, Liberman MC. Moverman DJ, et al. Among authors: liberman mc. Sci Rep. 2023 Nov 9;13(1):19456. doi: 10.1038/s41598-023-46859-6. Sci Rep. 2023. PMID: 37945811 Free PMC article.
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents.
Gao X, Tao Y, Lamas V, Huang M, Yeh WH, Pan B, Hu YJ, Hu JH, Thompson DB, Shu Y, Li Y, Wang H, Yang S, Xu Q, Polley DB, Liberman MC, Kong WJ, Holt JR, Chen ZY, Liu DR. Gao X, et al. Among authors: liberman mc. Nature. 2018 Jan 11;553(7687):217-221. doi: 10.1038/nature25164. Epub 2017 Dec 20. Nature. 2018. PMID: 29258297 Free PMC article.
531 results